---
layout: splash
title: 한미사이언스 (008930)
excerpt: 한미사이언스의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSPI
- P:기타금융
keywords: 한미사이언스, 008930
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 33,300 | <span style="color: cornflowerblue">-1.3<small>%</small></span> | P:기타금융 | 33.0 | 3.1 | 0.6<small>%</small> |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | P:기타금융 / 기타 금융업 |
| <span style="white-space:nowrap;">**산업**</span> | 항생제(세포탁심, 세포트리악손), 유산균정장제(메디락비타, 메디락베베), 위장관운동조절개선제(설프라이드), 고혈압치료제(유니바스크), 원료의약품, 식품 제조, 판매 |
| <span style="white-space:nowrap;">**상장**</span> | KOSPI / 1988년 6월 20일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 송영숙, 임종훈(공동 대표이사) |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.hanmiscience.co.kr](http://www.hanmiscience.co.kr){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 04&#x2011;25 | | [결산실적공시예고(안내공시)              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240425800521){:target="_blank"} |
| 04&#x2011;23 | | [주식등의대량보유상황보고서(일반)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240423000653){:target="_blank"} |
|  | | [주식등의대량보유상황보고서(일반)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240423000639){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![008930](/stock/images/008930.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 33,300 | <span style="color: cornflowerblue">-1.3<small>%</small></span> | <span style="color: tomato">1.8<small>%</small></span> | <span style="color: cornflowerblue">-18.1<small>%</small></span> | <span style="color: cornflowerblue">-23.7<small>%</small></span> | <span style="color: tomato">5.2<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: cornflowerblue">-21.9<small>%</small></span> | 63.1<small>%</small> | -0.35 | -43.5<small>%</small> | -22.2<small>%</small> | 0.5 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| P:기타금융 | 33.0 | 3.1 | 0.6<small>%</small> | - |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/008930/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=008930){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A008930&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=008930){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/008930){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/008930/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![008930](/stock/images/008930_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | -21.9<small>%</small> | 63.1<small>%</small> | -0.35 | -43.5<small>%</small> | -22.2<small>%</small> |
| 적립식[^fn_tech_metric_dca] | -7.9<small>%</small> | 62.5<small>%</small> | -0.13 | -45.4<small>%</small> | -17.1<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | -21.0<small>%</small> | 34.5<small>%</small> | -0.61 | -25.7<small>%</small> | -13.7<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | -40.4<small>%</small> | 48.3<small>%</small> | -0.84 | -45.8<small>%</small> | -23.8<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | -35.2<small>%</small> | 53.8<small>%</small> | -0.65 | -48.4<small>%</small> | -23.0<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | -40.5<small>%</small> | 51.2<small>%</small> | -0.79 | -42.2<small>%</small> | -28.0<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | -22.4<small>%</small> | 51.9<small>%</small> | -0.43 | -35.6<small>%</small> | -23.2<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | -40.9<small>%</small> | 53.1<small>%</small> | -0.77 | -45.2<small>%</small> | -32.1<small>%</small> |
| MACD[^fn_tech_metric_macd] | -29.0<small>%</small> | 51.5<small>%</small> | -0.56 | -39.1<small>%</small> | -18.8<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![008930](/stock/images/008930_corr.png){: .align-center}

|       | [씨젠](/096530/) | [넷마블](/251270/) | [한미약품](/128940/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [녹십자홀딩스](/005250/) | [하나투어](/039130/) | [대웅제약](/069620/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![008930](/stock/images/008930_2x.png){: .align-center}


> **관련 정보**

- [P:기타금융 업종 목록](/stats/sector/kospi_업종_기타금융_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}